.png "Laura Cappelli, MD photo")
Johns Hopkins School of Medicine
Baltimore, Maryland, United States
Dr. Laura C. Cappelli is an Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine, Division of Rheumatology, and a faculty member of the Johns Hopkins Arthritis Center. She earned her M.D. from Johns Hopkins. She completed her residency in internal medicine and fellowship in rheumatology at the Johns Hopkins Hospital. Dr. Cappelli earned an MHS in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Her primary research focus is rheumatologic adverse effects of cancer immunotherapy including the clinical characteristics, epidemiology, impact on patients, and biologic mechanisms of these adverse events. Her work involves collaborations with oncologists and laboratory investigators in rheumatology and oncology. Dr. Cappelli also co-chairs the Immune Related Toxicity Team at Johns Hopkins. In addition, she studies rheumatoid arthritis, focusing on patients with seronegative disease and on the use of autoantibodies as biomarkers.
Saturday, October 25, 2025
8:00 AM – 9:00 AM Central Time
Disclosure(s): Amgen: Consultant (Terminated); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing)
Saturday, October 25, 2025
8:00 AM – 8:10 AM Central Time
Disclosure(s): Amgen: Consultant (Terminated); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing)
Session I: irAEs and Agonism of Immune Checkpoints to Treat Autoimmune Disease
Saturday, October 25, 2025
9:00 AM – 10:30 AM Central Time
Disclosure(s): Amgen: Consultant (Terminated); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing)
